Ocular graft-versus-host disease (GVHD) is one of the most frequent and long-term complications affecting patients after haematopoietic stem cell transplantation. It is associated with significant morbidity and a marked reduction in quality of life. Although common, currently there are no widely accepted guidelines available for its management, and no suggested regime of treatment that is completely satisfactory. So far, prophylactic treatment strategies for ocular GVHD have yet to be developed and treatment is normally initiated based on symptoms often after permanent ocular tissue changes and surface damage has occurred. Here we describe a case of recurrent ocular GVHD and its associated complications that was highly refractory to treatment.
- anterior chamber
- haematology (incl blood transfusion)
- malignant and benign haematology
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors EG is a clinical ophthalmologist who was involved in the care of the patient and is first author of this paper having researched and written the majority of the content. EV was the treating haematologist in this case and who we worked in conjunction with to treat this difficult case of ocular GVHD. She has approved this edited version of the manuscript. CCM is second, being the overseeing consultant involved in the medical decisions pertaining the patients care, as well as providing direction, advice to the author and helping to edit the paper.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.